About this trial
There are vulnerabilities in post-discharge care transition for patients after undergoing resection of malignant gastrointestinal tumors. This study aims to investigate the possibility of utilizing Voice-Assisted Remote Symptom Monitoring System (VARSMS) to alleviate some of these challenges.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least 18 years old. Ages of subjects >89 will simply be reported as >90.
Scheduled for a GI surgery for management of a tumor in a participating hospital.
Fluent in oral and written English.
Has consistent and continued full access to an operational Wi-Fi for the duration of the study.
Disqualifiers
Unable to provide informed consent.
Not willing to commit to regular participation in the study to include daily use (40 days) of the study application.
Life expectancy of less than 60 days.
In the opinion of the investigator, participation in this study is contraindicated.
Trial design
Parallel
Treatments tested in this trial
Voice-Assisted Remote Symptom Monitoring System (VARSMS)
Other interventionUtilizing an Alexa Skill activated via an Amazon Echo Dot device, this system will administer two patient-reported outcomes measures to subjects. This will not be used as basis for diagnosis, nor for any clinical intervention.
Treatment groups
Trial outcomes
Primary outcomes
Custom questionnaire based on NCI PRO CTCAE (National Cancer Institute- Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events)
Daily symptom-based self-reported assessment on dyspnea, fever, melena, pain, wound healing, activities of daily living, sensorium, gastrointestinal motility, dysphagia, pitting edema, mood, and an option to mention symptoms not asked of. This is monitored by the research team, and any concerning finding, at the discretion of the site's physician, will be relayed to the subject's treating physician. Treating physician has final decision on whether to address referral by adjustment of management.
Secondary outcomes
SASSI (Subjective Assessment of Speech System Interfaces)
After interacting with the speech system for 40 days from the day after discharge, this questionnaire assesses the patient on their experience, having them rate the system based on system response accuracy, likeability, cognitive demand, annoyance, habitability, and speed.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.